Filter
2716
Filtered Results: 2716
Text search:
Global
Drug
Facility
Featured
Recommendations
263
New Publications
860
Language
Document type
No document type
1644
Guidelines
375
Studies & Reports
373
Manuals
125
Strategic & Response Plan
107
Training Material
37
Fact sheets
30
Situation Updates
13
Resource Platforms
7
Infographics
3
Brochures
1
App
1
Countries / Regions
India
136
Kenya
99
Global
87
Ethiopia
83
Nigeria
76
South Africa
74
Uganda
71
Tanzania
67
Malawi
59
Nepal
58
Liberia
55
Zambia
52
Ghana
50
Sierra Leone
50
Bangladesh
42
Namibia
41
Western and Central Europe
40
Myanmar / Burma
39
Rwanda
37
Africa
30
Eastern Europe
28
Ukraine
27
Zimbabwe
26
Lesotho
25
Asia
25
Cambodia
24
Latin America and the Carribbean
24
Philippines
23
South–East Asia Region
18
Syria
16
Mozambique
16
Senegal
15
Burkina Faso
15
Congo, Democratic Republic of
15
Botswana
15
Indonesia
15
Russia
12
Cameroon
11
East and Southern Africa
9
Eswatini/ Swaziland
9
South Sudan
8
Pakistan
8
Tajikistan
6
Benin
6
Haiti
6
West and Central Africa
6
Middle East and North Africa
6
Colombia
5
Laos
5
Guinea
5
Venezuela
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Sudan
5
Yemen
5
Thailand
4
Mexico
4
El Salvador
4
China
4
Afghanistan
4
Germany
4
Vietnam
4
Sri Lanka
4
Timor Leste/ East Timor
3
Peru
3
Brazil
3
Moldova
3
Palestine
3
Georgia
3
Central African Republic
3
Libya
3
Somalia
3
North Macedonia
2
Chile
2
Iran
2
Albania
2
Armenia
2
USA
2
Jordan
2
Gabon
2
France
2
Côte d’Ivoire / Ivory Coast
2
Lebanon
2
Papua New Guinea
2
Mali
2
Bhutan
2
Iraq
2
Madagascar
2
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Romania
1
Greece
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Countries
1229
Clinical Guidelines
233
Public Health
123
Women & Child Health
111
Key Resources
107
Capacity Building
47
Pharmacy & Technologies
36
Toolboxes
TB
345
HIV
299
AMR
158
COVID-19
125
Mental Health
96
Pharmacy
74
NTDs
74
Caregiver
57
Rapid Response
56
Malaria
51
NCDs
40
Conflict
35
Ebola & Marburg
33
Planetary Health
29
Refugee
27
Health Financing Toolbox
24
Global Health Education
23
Disability
21
Polio
15
Cholera
11
Natural Hazards
9
Specific Hazards
6
Zika
4
Social Ethics
2
Technical Note on Antimicrobial Resistance
This document reflects UNICEF’s response to the growing global threat of AMR to child survival, growth and development. It identifies UNICEF’s AMR-specific and AMR-sensitive actions in reducing infections, promoting access to and optimal use of antimic...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
Antimicrobial resistance (AMR) is a multifaceted, international public health problem, which poses a direct threat to the safety of the population of South Africa. A national response is required to complement the development of a global plan, as articulated in the WHO’s draft resolution EB134/37 ...
The issue of Antimicrobial resistance has become one of the most substantial health issues, prompting the World Health Assembly (WHA) to urge Member States to finalise tailor made national action plans by May 2017, aligning them with objectives of the Global Action Plan (GAP). These cover awareness,...
Antimicrobial resistance has become one of the most eminent threats to global health and a rising concern for healthcare specialists. All around the world, many common infections are becoming resistant to the antimicrobial medicines used to treat them, resulting in high morbidity and mortality with ...
This report is documenting the global incidence of attacks and threats against health workers, facilities, and transport around the world. The report cites 806 incidents of violence against or obstruction of health care in 43 countries and territories in ongoing wars and violent conflicts in 2020, r...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organization (WHO) and the UN committed to ending the TB epidemic through adoption of WHO’s End TB Strateg...
India contributes to 16% of the global maternal deaths and around 27% of global newborn deaths. Reducing the burden of maternal and newborn mortality and morbidity in urban poor settings today requires an expansion of effective Maternal and Newborn Health (MNH) care services and lowering the barrier...
This manual was developed based on the recommendations of a global technical consultation on child health in humanitarian emergencies co-organized by WHO and UNICEF at the end of 2003. WHO in collaboration with the Centre for Refugee and Disaster Response, Bloomberg School of Public Health, Johns Ho...
AMR is one of the Key priority of the global health security agenda action package, as well as it is one of the commitments of Ministry of Public Health Afghanistan to combat AMR. In Afghanistan because of war and some other political issues the borders of the country are not well secured and well c...
In preparing this paper, the Pharmacovigilance Group of the Pan American Health Organization’s Pan American Network for Drug Regulatory Harmonization (PANDRH) adopted the perspective of PAHO/WHO, which considers Pharmacovigilance, an essential component of public health programs. Its intention was...
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio...
Evidence for improving community health supply chains from Ethiopia, Malawi and Rwanda. Journal of Global Health vol. 4 No.2 (2014)
The Extending Service Delivery (ESD) project has developed Healthy Timing and Spacing of
Pregnancy: A Trainer’s Reference Guide as a resource for trainers in developing in-service training
for facility-based healthcare providers and community health workers (chws) who already have
some basic ex...
The road map 2030 was developed by WHO through an extensive global consultation, with indicators set for measuring progress against targets and milestones. This compendium of indicators provides a comprehensive and standardized listing of recommended indicators, including the 70 core indicators pres...
